Recognition of Non-Operating Income and Expenses
The Company (D.Western Therapeutics Institute, Inc.)
Bank deposits and borrowings from financial institutions
Interest received on bank deposits and interest paid on borrowings from financial institutions
Non-operating income (interest received): ¥1.266 million; non-operating expenses (interest paid): ¥3.197 million
Cumulative consolidated period for the first quarter of the fiscal year ending December 2026 (1 January 2026 to 31 March 2026)
| Item | Details |
|---|---|
| Event name | Recognition of Non-Operating Income and Expenses |
| Subject Entity | The Company (D.Western Therapeutics Institute, Inc.) |
| Target Locations / Products | Bank deposits and borrowings from financial institutions |
| Cause | Interest received on bank deposits and interest paid on borrowings from financial institutions |
| Amount of Impact on Business Performance | Non-operating income (interest received): ¥1.266 million; non-operating expenses (interest paid): ¥3.197 million |
| Accounting period in which recognized | Cumulative consolidated period for the first quarter of the fiscal year ending December 2026 (1 January 2026 to 31 March 2026) |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company states that it recognized non-operating income because it received interest on bank deposits, and non-operating expenses because it paid interest on borrowings from financial institutions.